We demonstrated that NF-κB inhibitor could abolish the effects of Cofilin-1 overexpression, suggesting Cofilin-1 is inducing AKI and other cellular defects via the NF-κB pathway. The gene discussed is CFL1; the disease is acute kidney injury.